Chen, Liang, Li, Qingnian, Lei, Lei, Li, Tianyu (2018) Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways. Life Sciences, 209. 420-429 doi:10.1016/j.lfs.2018.08.039
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways | ||
| Journal | Life Sciences | ||
| Authors | Chen, Liang | Author | |
| Li, Qingnian | Author | ||
| Lei, Lei | Author | ||
| Li, Tianyu | Author | ||
| Year | 2018 (September) | Volume | 209 |
| Publisher | Elsevier BV | ||
| DOI | doi:10.1016/j.lfs.2018.08.039Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 12957985 | Long-form Identifier | mindat:1:5:12957985:6 |
| GUID | 0 | ||
| Full Reference | Chen, Liang, Li, Qingnian, Lei, Lei, Li, Tianyu (2018) Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways. Life Sciences, 209. 420-429 doi:10.1016/j.lfs.2018.08.039 | ||
| Plain Text | Chen, Liang, Li, Qingnian, Lei, Lei, Li, Tianyu (2018) Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways. Life Sciences, 209. 420-429 doi:10.1016/j.lfs.2018.08.039 | ||
| In | (n.d.) Life Sciences Vol. 209. Elsevier BV | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
